We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+29.88%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.78B
AUM Growth
+$40.3M
Cap. Flow
-$635M
Cap. Flow %
-22.8%
Top 10 Hldgs %
41.28%
Holding
156
New
21
Increased
23
Reduced
32
Closed
45

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$77.3M
2
ACHN
Achillion Pharmaceuticals
ACHN
+$35.7M
3
NVRO
NEVRO CORP.
NVRO
+$33M
4
VNDA icon
Vanda Pharmaceuticals
VNDA
+$23.3M
5
AGN
Allergan Inc
AGN
+$22.9M

Top Sells

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$46M
2
ABBV icon
AbbVie
ABBV
+$44.3M
3
KITE
Kite Pharma, Inc.
KITE
+$36M
4
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$30.9M
5
WBA
Walgreens Boots Alliance
WBA
+$28.6M

Sector Composition

Rank Sector Weight
1 Healthcare 52.44%
2 Financials 2.69%
3 Technology 0.73%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
101
Cigna
CI
$74.5B
– –
-166,929
Closed -$15.1M
CI icon
102
PUT
Cigna
CI
$74.5B
– –
-375,000
Closed -$34M
FOLD
103
DELISTED
Amicus Therapeutics
FOLD
– –
-480,000
Closed -$2.86M
GMED icon
104
Globus Medical
GMED
$10.5B
– –
-1,278,235
Closed -$25.1M
HCA icon
105
HCA Healthcare
HCA
$82.3B
– –
-71,303
Closed -$5.03M
HCA icon
106
PUT
HCA Healthcare
HCA
$82.3B
– –
-750,000
Closed -$52.9M
IRWD icon
107
Ironwood Pharmaceuticals
IRWD
$635M
– –
-43,764
Closed -$475K
MDT icon
108
Medtronic
MDT
$106B
– –
-204,800
Closed -$12.7M
OPK icon
109
Opko Health
OPK
$899M
– –
-75,000
Closed -$638K
PRPO icon
110
Precipio
PRPO
$44M
– –
-8
Closed -$260K
PRTA icon
111
Prothena Corp
PRTA
$453M
– –
-27,500
Closed -$609K
SEM
112
DELISTED
Select Medical
SEM
– –
-176,916
Closed -$1.15M
SGMO
113
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-50,000
Closed -$539K
THC icon
114
Tenet Healthcare
THC
$16.8B
– –
-82,960
Closed -$4.93M
THC icon
115
PUT
Tenet Healthcare
THC
$16.8B
– –
-750,000
Closed -$44.5M
WBA
116
DELISTED
Walgreens Boots Alliance
WBA
– –
-482,000
Closed -$28.6M
CMRX
117
DELISTED
Chimerix, Inc.
CMRX
– –
-406,100
Closed -$11.2M
VIRX
118
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-1,065
Closed -$1.6M
CBAY
119
DELISTED
Cymabay Therapeutics
CBAY
– –
-513,206
Closed -$3.51M
ICPT
120
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-50,000
Closed -$11.8M
ABMD
121
DELISTED
Abiomed Inc
ABMD
– –
-435,934
Closed -$10.8M
DRNA
122
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-2,428,569
Closed -$30.9M
HMSY
123
DELISTED
HMS Holdings Corp.
HMSY
– –
-29,316
Closed -$553K
BSTC
124
DELISTED
BioSpecifics Technologies Corp.
BSTC
– –
-168,883
Closed -$5.96M
MNK
125
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-250,000
Closed -$22.5M
2 3 4
5
6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q4 2014 Portfolio in Review

As of Q4 2014, Deerfield Management held 156 positions worth $2.78B, up 1.5% from $2.74B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Deerfield Management withdrew a net $635M in Q4 2014, closing 45 positions and reducing 32 holdings. Its most notable exit was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 47% a quarter earlier, followed by Financials and Technology.

Against the trend, Deerfield Management opened a new position in Achillion Pharmaceuticals worth $35.8M.

  • Deerfield Management's largest Q4 2014 buy was Achillion Pharmaceuticals: 2,920,300 shares worth $35.8M.
  • Deerfield Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014, an estimated $77.3M increase.
  • Deerfield Management's biggest Q4 2014 reduction was Kite Pharma, Inc., cutting an estimated $36M.
  • Deerfield Management fully exited MALLINCKRODT PUBLIC LIMITED COMPANY in Q4 2014, selling an estimated $46M.
  • Deerfield Management's ten largest holdings make up 41% of its $2.78B portfolio in Q4 2014.
  • Deerfield Management opened 21 new positions and closed 45 in Q4 2014.
  • Deerfield Management's portfolio value rose 1.5% quarter-over-quarter to $2.78B.

Based on Deerfield Management's 13F filing for Q4 2014, filed 17 Feb 2015.